Advertisement
Berita Forex
Swiss Stocks Close Notably Lower
Swiss stocks tumbled on Friday, in line with markets across the globe as rising fears about a global recession rendered the mood bearish and triggered heavy selling at the counters.
RTTNews |
975 hari yang lalu
European Stocks Close Sharply Lower As Recession Fears Weigh
European stocks closed sharply lower on Friday, extending recent losses, as mounting fears about a global recession rendered the mood extremely bearish.
RTTNews
|
975 hari yang lalu
Canadian Stocks Drifting Lower On Recession Worries
Canadian shares are notably lower around noon on Friday, with rising concerns about a global recession triggering heavy selling in several sectors.
RTTNews
|
975 hari yang lalu
U.S. Consumer Sentiment Shows Modest Improvement In September, Inflation Expectations Dip
A report released by the University of Michigan on Friday showed a modest improvement in U.S. consumer sentiment in the month of September. The University of Michigan said its consumer sentiment index inched up to 59.5 in September from 58.2 in August. Economists had expected the index to rise to 60.0.
RTTNews
|
975 hari yang lalu
U.S. Bancorp, Mitsubishi UFJ Financial Agree To Extend Purchase Agreement
U.S. Bancorp (USB) and Mitsubishi UFJ Financial Group or MUFG (MTU) on Friday have mutually agreed to exercise their right under the purchase agreement for U.S. Bank's acquisition of MUFG Union Bank's core regional banking franchise to extend the outside termination date to December 31, 2022 from September 30, 2022.
RTTNews
|
975 hari yang lalu
Russia Lowers Key Rate By 50 Bps
Russia's central bank lowered its key rate by a half-percentage point on Friday, after delivering sharp reductions since April. The Board of Directors of Bank of Russia decided to reduce the benchmark rate by 50 basis points to 7.50 percent from 8.00 percent.
RTTNews
|
975 hari yang lalu
FTSE-100 Hovers Near Flatline
The FTSE-100 benchmark of the London Stock Exchange is currently close to the flatline, unlike much of its European peers that have declined close to 1 percent. Lingering concerns of an economic slowdown rattled market sentiment.
RTTNews
|
975 hari yang lalu
more news
Novavax's Nuvaxovid COVID-19 Vaccine Gets Expanded EUA In Taiwan For Use In Adolescents
Biotechnology company Novavax, Inc. (NVAX) announced Friday that the Taiwan Food and Drug Administration (TFDA) has granted expanded emergency use authorization (EUA) for Nuvaxovid (NVX-CoV2373) COVID-19 vaccine for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in adolescents aged 12 through 17.
RTTNews
|
975 hari yang lalu
Novavax's Says Nuvaxovid COVID-19 Vaccine Now Available In Israel For Individuals Aged 12 And Older
Biotechnology company Novavax, Inc. (NVAX) announced Friday that the Israel Ministry of Health has granted an import and use permit which provides individuals aged 12 and older access to the Nuvaxovid (NVX-CoV2373) COVID-19 vaccine.
RTTNews
|
975 hari yang lalu
Bay Street Likely To See Weak Start
Canadian shares look headed for a negative start on Friday, tracking weak cues from Asian and European markets amid rising fears about a global recession.
RTTNews
|
975 hari yang lalu
European Stocks Down Firmly In Negative Territory On Recession Fears
European stocks are down in negative territory a little past noon on Friday amid rising concerns about a recession in the U.S. and several other major economies due to rising interest rates.
RTTNews
|
975 hari yang lalu
Pound Moves Down As Weak Retail Sales Data Fuels Recession Concerns
The pound fell sharply against its major counterparts in the European session on Friday, as U.K. retail sales declined more than expected in August, suggesting that the economy is falling into a recession.
RTTNews
|
975 hari yang lalu
Agios Says CHMP Adopts Positive Opinion For PYRUKYND To Treat Pyruvate Kinase Deficiency In Adults
Agios Pharmaceuticals, Inc. (AGIO) announced Friday that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion on September 15, 2022, recommending the granting of a marketing authorization for PYRUKYND (mitapivat) for the treatment of pyruvate kinase (PK) deficiency in adult patients.
RTTNews
|
975 hari yang lalu
Stay up to date!
Add Berita to your browser
Add To Chrome
